The use of artificial intelligence (AI) in medical devices has grown significantly, driving advances in diagnosis, monitoring, and patient treatment. However, this progress comes with the need to establish clear regulations and guidelines to ensure safety, efficacy, and accountability in its application.
The implementation of specific regulations and guidelines for AI in the medical device sector is crucial to foster innovation without compromising patient safety. While the European Union leads with a comprehensive framework, countries such as the United States, United Kingdom, Canada, and Spain are developing complementary approaches to address the challenges and opportunities presented by this emerging technology.
Do you want to know the main guidelines applied to AI in different regions of the world? In this article, we share a summary of the most updated regulatory initiatives prepared by our expert team at Ambit BST:
European Union: Leading with a comprehensive approach
The European Union (EU) is implementing a robust framework to govern AI, highlighting its commitment to a risk-based approach.
The regulatory bodies in this region are the European Commission (EC), European Medicines Agency (EMA), and European Data Protection Board (EDPB).
- Artificial Intelligence Act (EU 2024/1689)
This regulation is the pillar of AI regulation in the EU. It establishes a comprehensive governance approach, categorizing AI systems according to their risk level (minimal, limited, high, and unacceptable) and imposes strict requirements for high-risk systems, such as those used in medical devices. - AI Liability Directive Proposal
It is a legislative proposal by the EC addressing civil liability for AI systems, focusing on compensating possible damages and ensuring fairness in cases of malfunction. - EMA Draft Reflection Paper
This developing guideline analyzes how AI can be integrated into the life cycle of medicinal products, with a focus on safety and innovation, including development, authorization, and post-market monitoring. - Cybersecurity of AI in the AI Act
Technical report evaluating specific cybersecurity requirements for AI systems, complementing the AI Act framework.
United States: A practical and technical approach
In the United States, regulatory initiatives and guidelines focus on risk management and the secure development of AI systems.
The regulatory bodies in the United States are the Food and Drug Administration (FDA), National Institute of Standards and Technology (NIST), and the government White House.
- White House Executive Order on AI
This document establishes a national directive to promote safe and ethical AI development across all industries, underlining the importance of transparency, fairness, and safety in critical applications such as medical devices. - NIST AI Risk Management Framework 1.0
This comprehensive framework provides detailed guidelines for managing risks associated with AI systems, considering factors like safety, privacy, and resilience to help organizations identify, manage, and mitigate AI-associated risks. - NIST AI 600-1: GenAI Profile
Specific guidelines for managing risks related to generative AI, a rapidly growing technology. - Marketing Submission Recommendations for AI-Enabled Device Software
The FDA recently published these recommendations to assist Medical Devices manufacturers in incorporating a predetermined change control plan for AI-based medical device software, ensuring adjustments do not compromise safety or performance. - NIST AI 100-4: Reducing Risks Posed by Synthetic Content
Guideline to minimize risks related to synthetic content.
United Kingdom: Evolving regulation and safety
The United Kingdom focuses on establishing an adaptive regulatory framework combining innovation and safety.
The regulatory bodies in the United Kingdom are the "Medicines and Healthcare products Regulatory Agency" (MHRA) and the "Artificial Intelligence Standards Institute" (AISI).
- AI Regulation Bill
This bill seeks to be the primary legislation for AI in the United Kingdom. Although still in proposal phase, it aims to harmonize AI ethical and technical standards with medical device requirements. - MHRA AI Impact
Specific guidance issued by MHRA detailing how to regulate the impact of AI on medical products, including learning-based and generative devices. - Pre-Deployment Evaluation of Anthropic's Upgraded Claude 3.5 Sonnet
Document published by AISI evaluating the safety and effectiveness of an advanced AI model prior to its deployment and implementation.
Canada: A proactive and collaborative approach
Canada has adopted a mixed strategy combining regulation and voluntary guidelines.
The regulatory bodies in Canada are "Health Canada" (HC) and "Innovation, Science and Economic Development Canada" (ISED).
- AIDA (Artificial Intelligence and Data Act)
Proposed national regulation establishing legal requirements for AI development and use in various sectors, including medical devices, with a focus on transparency and supervision. - HC ML Medical Devices
Developing guidance by Health Canada for machine learning use in medical devices, seeking to ensure safety and efficacy. - Guide on the Use of Generative Artificial Intelligence
Published by ISED, this document details how to implement generative AI in an ethical and responsible manner in sectors such as healthcare.
Spain: National strategies for AI development
Spain adopts a strategic approach to foster AI development, aligned with European ethical and regulatory values.
In Spain, AI use is supervised by national bodies such as the State Secretariat for Digitalization and Artificial Intelligence (SEDIA) and the Spanish Agency for Supervision of Artificial Intelligence (AESIA, in process of creation), but is fundamentally framed within EU guidelines and regulations.
National strategies seek to boost the development and ethical use of AI, ensuring technological innovations benefit society in an equitable and responsible manner.
- Estrategia Nacional de Inteligencia Artificial (ENIA):This plan establishes AI priorities in Spain, including its ethical and responsible application in critical sectors such as medical devices.
- European Regulation:Spain adopts European regulations such as the AI Act, with AESIA playing a crucial role in supervising its implementation.
Always stay up to date with regulations
With regulations and guidelines in constant evolution, staying updated is essential to leverage AI opportunities safely and effectively. Through AReIA (Advanced Regulatory Intelligence Assistant), at Ambit we provide you with the necessary tools and information to adapt to this dynamic regulatory environment and get the most out of artificial intelligence in medical devices.
Our AReIA service is designed to keep our clients informed about the latest regulations, guidelines, and technological advances. With it, you can access personalized analysis, key regulatory summaries, and tailored recommendations for your needs, ensuring compliance and competitiveness.
Key benefits of AReIA:
- Always up to date with regulations
Guarantees that your team is always aware of the latest regulatory changes to remain in compliance in an orderly manner and without surprises. - Tailored Compliance Manager
Informs you of any regulatory change to ensure compliance according to regulations affecting your products and markets. - Continuous Task Manager
Digitalizes the regulatory task assignment and tracking process, managing regulatory changes in an integrated single platform. - Maximize your team's value
Reduces time, facilitates compliance, and provides visibility into regulatory activities. AReIA not only ensures compliance, but also enhances the strategic value of Regulatory Affairs within your company.
Connect with Us
At Ambit BST, we work closely with our clients to provide customized solutions that ensure regulatory compliance and quality. We are not only experts in Medical Devices, but we also offer consulting, auditing, and specialized training services.
"Compliance is not just a requirement, it is a growth opportunity."
Do not hesitate to contact us by clicking here. Achieve business success by knowing everything about artificial intelligence in medical devices!
At AMBIT BST, we have been experts for over 20 years in the development of strategies and IT solutions. We help the pharmaceutical, medical device, and IVD (in vitro diagnosis) medical device sectors to comply with regulations throughout the entire product lifecycle. We design and implement innovative infrastructures thanks to a global service offering as an enabling lever for digital transformation.
Cuéntanos tu opinión